Long-term outcome of patients with severe pulmonary hypertension undergoing transcatheter aortic valve implantation
TAVI patients with severe PH represent a high-risk subgroup with unfavourable acute outcomes and increased one-year and long-term mortality. Moreover, the presence of severe PH is associated with increased rates of acute adverse events, including bleeding, need for PPM implantation and renal failure.
Authors
- L. Hannen
- Oliver D. Bhadra
- Lara Waldschmidt (ORCID: https://orcid.org/0009-0008-2129-7145)
- Johannes Schirmer (ORCID: https://orcid.org/0000-0003-2203-1353)
- David Grundmann (ORCID: https://orcid.org/0000-0001-8100-7594)
- Sebastian Ludwig (ORCID: https://orcid.org/0000-0002-5752-4951)
- Moritz Seiffert (ORCID: https://orcid.org/0000-0002-3940-9079)
- Lisa Voigtlaender-Buschmann
- Ina von der Heide
- Simon Pecha
- Niklas Schofer
- Lenard Conradi
- Hermann Reichenspurner
- Andreas Schaefer
- Jessica Weimann
- Till J. Demal
Institutions
- Ohio Heart & Vascular Center (US)
- BG University Hospital Bergmannsheil Bochum (DE)
Publication Details
- Journal
- Frontiers in Cardiovascular Medicine
- Published
- 2026-01-30
- DOI
- https://doi.org/10.3389/fcvm.2025.1678025
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00